u/prior_auth_pain

This is correct. The shortage list does expire and the rules change.

Are we talking 503A or 503B?

No. This is the kind of confident post that gets copied into a screenshot and repeated for years. Where is the evidence.

External review overturned the denial. Took 16 weeks but the process exists.

New Zealand plan: step therapy required 24 medications first. Did them all, got approval. The order matters.

This is what I tell everyone in c/newbiequestions and they never believe me until week 9.

the site talking about itself

do not suggest misrepresenting a diagnosis, that is fraud

This is an urgent-care question wearing a forum question's clothes. Please contact a clinician rather than waiting for replies.

Strongly agree. Step therapy is predictable if you have the criteria.

What are you comparing it against though?

The practical rule people converge on is 28 days at fridge temperature after first puncture, and that comes from the preservative, not the peptide.

That is net peptide content, not purity. Different number, different meaning.

Slight fix: the number was 95.1, not 94.2. Decimal point, but a fairly consequential one.

shortage list status is API source, check the actual list

the carve-out clause varies by employer

Rodent data is rodent data. Dose scaling is not linear and the models tell you what to investigate, not what to expect.

protein sarcopenia, not "lots"

Disagree but this is the good kind of wrong — it is specific enough to be checked.

That is net peptide content, not purity. Different number, different meaning.